Identification Generic Name (2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE DrugBank Accession Number DB07290 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE (DB07290) ×  Close Weight Average: 346.374  Monoisotopic: 346.099870623  Chemical Formula C 14 H 19 FN 2 O 5 S Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Lethal factor Not Available Bacillus anthracis Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as benzenesulfonamides. These are organic compounds containing a sulfonamide group that is S-linked to a benzene ring. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Benzenesulfonamides Direct Parent Benzenesulfonamides Alternative Parents Alpha amino acids and derivatives  /  Benzenesulfonyl compounds  /  Toluenes  /  Fluorobenzenes  /  Oxanes  /  Organosulfonamides  /  Aryl fluorides  /  Aminosulfonyl compounds  /  Hydroxamic acids  /  Oxacyclic compounds  /  Dialkyl ethers  /  Hydrocarbon derivatives  /  Carbonyl compounds  /  Organic oxides  /  Organofluorides  /  Organonitrogen compounds  /  Organopnictogen compounds 
 
 
  show 7 more Substituents Alpha-amino acid or derivatives  /  Aminosulfonyl compound  /  Aromatic heteromonocyclic compound  /  Aryl fluoride  /  Aryl halide  /  Benzenesulfonamide  /  Benzenesulfonyl group  /  Carbonyl group  /  Carboxylic acid derivative  /  Dialkyl ether  /  Ether  /  Fluorobenzene  /  Halobenzene  /  Hydrocarbon derivative  /  Hydroxamic acid  /  N-substituted-alpha-amino acid  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organic sulfonic acid or derivatives  /  Organofluoride  /  Organohalogen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Organosulfonic acid amide  /  Organosulfonic acid or derivatives  /  Organosulfur compound  /  Oxacycle  /  Oxane  /  Sulfonyl  /  Toluene 
 
 
  show 23 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key LUCFRFDOOYLALP-CYBMUJFWSA-N InChI InChI=1S/C14H19FN2O5S/c1-9-8-11(2-3-12(9)15)23(20,21)17-13(14(18)16-19)10-4-6-22-7-5-10/h2-3,8,10,13,17,19H,4-7H2,1H3,(H,16,18)/t13-/m1/s1 IUPAC Name (2R)-2-(4-fluoro-3-methylbenzenesulfonamido)-N-hydroxy-2-(oxan-4-yl)acetamide SMILES [H][C@@](NS(=O)(=O)C1=CC(C)=C(F)C=C1)(C1CCOCC1)C(=O)NO References General References Not Available External Links PubChem Compound 4369384 PubChem Substance 99443761 ChemSpider 3571962 BindingDB 8503 ChEMBL CHEMBL204593 ZINC ZINC000003818457 PDBe Ligand 915 PDB Entries 1yqy Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 1.16 mg/mL ALOGPS logP 0.12 ALOGPS logP 0.76 Chemaxon logS -2.5 ALOGPS pKa (Strongest Acidic) 8.68 Chemaxon pKa (Strongest Basic) -4.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 104.73 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 81.08 m 3 ·mol -1 Chemaxon Polarizability 32.84 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.7826 Blood Brain Barrier - 0.6963 Caco-2 permeable - 0.6156 P-glycoprotein substrate Substrate 0.6174 P-glycoprotein inhibitor I Non-inhibitor 0.5494 P-glycoprotein inhibitor II Non-inhibitor 0.9838 Renal organic cation transporter Non-inhibitor 0.9157 CYP450 2C9 substrate Non-substrate 0.6038 CYP450 2D6 substrate Non-substrate 0.8053 CYP450 3A4 substrate Non-substrate 0.5588 CYP450 1A2 substrate Non-inhibitor 0.775 CYP450 2C9 inhibitor Non-inhibitor 0.6427 CYP450 2D6 inhibitor Non-inhibitor 0.8762 CYP450 2C19 inhibitor Non-inhibitor 0.5772 CYP450 3A4 inhibitor Non-inhibitor 0.7271 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8092 Ames test Non AMES toxic 0.6022 Carcinogenicity Non-carcinogens 0.8001 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.5334 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9684 hERG inhibition (predictor II) Inhibitor 0.5    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more Binding Properties × Property Measurement pH Temperature (°C) References IC 50 (nM) 54 7 22 A30832 
 
 
  Details 
 
 
   Binding Properties 1.  Lethal factor Kind Protein Organism Bacillus anthracis Pharmacological action Unknown General Function Metallopeptidase activity Specific Function One of the three proteins composing the anthrax toxin, the agent which infects many mammalian species and that may cause death. LF is the lethal factor that, when associated with PA, causes death. ... Gene Name lef Uniprot ID P15917 Uniprot Name Lethal factor Molecular Weight 93769.58 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:20 / Updated at June 12, 2020 16:52 